• Fluticasone/salmeterol • Ipratropium/salbutamolThis pharmacology-related combivent nacl is a stub. You can help Wikipedia by expanding it.Retrieved from "http://en.wikipedia.org/wiki/Ipratropium/salbutamol"Categories: Pharmacology stubs | Bronchodilators.

ofIpratropium Muscarinic antagonistSalbutamol Short-acting ?2-adrenergic agonistIdentifiersCAS number ?ATC code combivent nacl ?PubChem ?Therapeutic considerationsPregnancy cat. ?Legal statusRoutes InhalationThe combination preparation ipratropium/salbutamol is a formulation containing combivent nacl bromide and salbutamol sulfate (albuterol combivent nacl used in the management of chronic obstructive pulmonary disease (COPD) and asthma. It is marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser preparations under the trade name Combivent.[hide]v • d • eDrugs for obstructive airway diseases: asthma/COPD (R03)Adrenergics, inhalants Short acting ?2-agonists: Salbutamol/Levosalbutamol • Fenoterol • TerbutalineLong acting ?2-agonists (LABA): combivent nacl • Clenbuterol • Formoterol • Salmeterolother: Epinephrine combivent nacl Isoproterenol • OrciprenalineGlucocorticoids Beclometasone • Budesonide • Ciclesonide • combivent nacl • MometasoneAnticholinergics Ipratropium • TiotropiumMast cell.

• NedocromilXanthines Aminophylline • Theobromine • TheophyllineLeukotriene antagonists Montelukast • Pranlukast Montelukast.